NSW State Committee
Chaired by: Lis Boyce, Partner, Piper Alderman
Committee members:
- Ms Lis Boyce, Partner, Piper Alderman
- Dr Joe Badolato, Chief Business Development Officer, Adjutor Healthcare
- Katja Beitat, Group Executive – Health, Cicada Innovations
- Dr Kathryn Gibson, Executive Director – Rheumatology, Eli Lilly Australia
- Leah Goodman, Chief Executive Officer, Biointelect
- Dr Brenton Hamdorf, Precinct Manager, Thermo Fisher Scientific
- Dr Laura Issa, Chief Scientific Officer, Facio Biotherapies Pty Ltd
- Dr Chris Marquis, Director of the Recombinant Products Facility, University of NSW
- Kristine McGrath, Associate Professor, University of Technology
- Prof Brett Neilan, Head of School Environmental and Life Sciences, The University of Newcastle, Knowledge Exchange and Enterprise (KEE)
- Andre Serobian, Chief Innovation & Commercialisation Officer, UNSW Sydney - RNA Institute
- Anita van der Meer, Head of Business Development and Partnerships, Viral Vector Manufacturing Facility